1. Introduction
confusion, dyspnea, illness, fatigue, cognitive impairment, anxiety, pain, infection, depression
INFECTION, COVID-19 INFECTION, ACUTE COVID-19 INFECTION, LONG COVID
Study objective: Long COVID patients can experience high levels of impairment in their cognitive function and mental health. Using a parallel randomized control trial, we evaluated the effectiveness of a neuro-meditation program to reduce cognitive impairment in patients with long COVID. Methods: A total of 34 patients with long COVID were randomized to an intervention group (G-Int; The devastating health consequences of acute COVID-19 infection have been thoroughly characterized, and growing concerns regarding potential long-term incidences have arisen for patients who survive the infection and may experience long-term effects. Indeed, many survivors have revealed chronic and debilitating symptoms long after viral recovery, despite mild illness severity at onset [Few studies have documented the most common persistent symptoms after severe COVID-19 infection. These symptoms include fatigue, dyspnea, “brain fog”/various cognitive symptoms, pain, anxiety, depression, and gastrointestinal issues [Interventions that support mental health and psychological well-being have been shown to help people with physical health challenges [The purpose of the present study was thus to evaluate the influence of an MBI program on cognitive performance in long COVID patients. We hypothesized that a four-week MBI using neuro-meditation would improve the overall cognitive functioning of all participants and reduce states of mental and physical fatigue, and confusion.